ABC | Volume 114, Nº4, April 2020

Original Article Schmidt et al. Physical fitness and quality of life in HFpEF Arq Bras Cardiol. 2020; 114(4):701-707 Table 3 – Partial correlation between quality of life dimensions and physical fitness components Dynamic balance and mobility Upper body strength Cardiorespiratory fitness Body composition 8FUG Handgrip 6MWT BMI % FM FFM MLHFQ total 0.563 (0.008) -0.118 (0.611) -0.539 (0.012) 0.208 (0.366) -0.012 (0.957) 0.372 (0.097) MLHFQ physical 0.529 (0.014) -0.261 (0.254) -0.478 (0.028) 0.260 (0.255) -0.027 (0.909) 0.353 (0.116) MLHFQ emotional 0.597 (0.004) -0.023 (0.919) -0.394 (0.077) 0.199 (0.388) 0.002 (0.993) 0.297 (0.191) Adjusted for age, gender and NYHA functional class. 8FUG, 8-foot up and go test. 6MWT, six-minute walk test. BMI, body mass index. FM, fat mass. FFM, free fat mass. MLHFQ, Minnesota Living with Heart Failure Questionnaire. Data are r (p). Table 4 – Stepwise regression analysis assessing which physical fitness components were independently associated with specific quality of life dimensions β B R2 p MLHFQ total Ln 8FUG 0.651 5.015 0.424 0.001 MLHFQ physical Ln 8FUG 0.570 3.788 0.324 0.040 MLHFQ emotional Ln 8FUG 0.611 3.003 0.373 0.002 Ln 8FUG: natural logarithm of 8-foot up and go test; MLHFQ: Minnesota Living with Heart Failure Questionnaire; β : standardized regression coefficient; B: non-standardized regression coefficient; R 2 : adjusted coefficient of determination. 1. Dunlay SM, Roger VL, Redfield MM. Epidemiology of heart failure with preserved ejection fraction. Nat Rev Cardiol. 2017;14(10):591-602. 2. Edelmann F, Stahrenberg R, Polzin F, Kockskamper A, Dungen HD, Duvinage A, et al. Impaired physical quality of life in patients with diastolic dysfunction associates more strongly with neurohumoral activation than with echocardiographic parameters: quality of life in diastolic dysfunction. AmHeart J. 2011;161(4):797-804. 3. Rodriguez-Artalejo F, Guallar-Castillon P, Pascual CR, Otero CM, Montes AO, Garcia AN, et al. Health-related quality of life as a predictor of hospital readmission and death among patients with heart failure. Arch InternMed. 2005;165(11):1274-9. 4. Holland DJ, Kumbhani DJ, Ahmed SH, Marwick TH. Effects of treatment on exercise tolerance, cardiac function, and mortality in heart failure with preserved ejection fraction. A meta-analysis. J Am Coll Cardiol. 2011;57(16):1676-86. 5. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37(27):2129-200. 6. NolteK,Herrmann-LingenC,WachterR,GelbrichG,DungenHD,Duvinage A, et al. Effects of exercise training on different quality of life dimensions in heart failure with preserved ejection fraction: the Ex-DHF-P trial. Eur J Prev Cardiol. 2015;22(5):582-93. 7. Kitzman DW, Brubaker PH, Morgan TM, Stewart KP, Little WC. Exercise training in older patients with heart failure and preserved ejection fraction: a randomized,controlled,single-blindtrial.CircHeartFail.2010;3(6):659-67. 8. Rikli RE, Jones CJ. Development and validation of criterion-referenced clinically relevant fitness standards for maintaining physical independence in later years. Gerontologist. 2013;53(2):255-67. 9. TheWorldHealthOrganizationQualityofLifeAssessmentGroup.TheWorld HealthOrganizationQuality of Life Assessment (WHOQOL): development and general psychometric properties. Soc Sci Med. 1998;46(12):1569-85. 10. Edelmann F, Gelbrich G, Dungen HD, Frohling S, Wachter R, Stahrenberg R, et al. Exercise training improves exercise capacity and diastolic function in patients with heart failure with preserved ejection fraction: results of the Ex-DHF (Exercise training in Diastolic Heart Failure) pilot study. J Am Coll Cardiol. 2011;58(17):1780-91. 11. McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Böhm M, Dickstein K, et al. ESCGuidelines for the diagnosis and treatment of acute and chronic heart failure 2012. European journal of heart failure. 2012;14(8):803-69. 12. Mancia G, Grassi G, Redon J. Manual of Hypertension of the European Society of Hypertension. 2nd ed. Boca Raton:CRC Press; 2014. 13. Lohman TG, A.F. Roche, and R. Martorell. Anthropometric Standardization Reference Manual. Champaign, IL: Human Kinetics Books; 1988. 14. Riley L, Guthold R, CowanM, Savin S, Bhatti L, Armstrong T, et al. TheWorld Health Organization STEPwise Approach to Noncommunicable Disease Risk-Factor Surveillance: Methods, Challenges, and Opportunities. Am J Public Health. 2016;106(1):74-8. 15. WHO. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser. 2000;894:1-253. 16. Dolgin M. Nomenclature and criteria for diagnosis of diseases of the heart and great vessels. TheCriteria Committee of theNewYorkHeart Association. 9 ed. Boston: Little, Brown & Co; 1994. 253-6 p. References 706